Literature DB >> 7829479

GATA-3 dominant negative mutant. Functional redundancy of the T cell receptor alpha and beta enhancers.

V M Smith1, P P Lee, S Szychowski, A Winoto.   

Abstract

The GATA family of transcription factors regulates a wide variety of genes, including those involved in differentiation of erythrocytes and T lymphocytes. We report here the creation of a dominant negative mutant of GATA-3, KRR, which effectively blocks wild-type GATA-1, GATA-2, and GATA-3 transactivation when co-expressed in transient assays. KRR was generated by site-directed mutagenesis while investigating a putative activation domain of GATA-3, located between its two zinc fingers. The GATA-3 KRR mutation does not affect expression, nuclear translocation, or the ability to bind to a consensus GATA sequence. KRR can suppress the activity of the minimal T cell receptor (TCR) alpha and beta enhancers by 12- and 3.4-fold, respectively. However, KRR did not have a significant effect on the activity of larger TCR-alpha and -beta enhancer fragments. Thus, functional redundancy in the TCR-alpha and -beta enhancers can compensate for the loss of GATA-3 activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829479     DOI: 10.1074/jbc.270.4.1515

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Molecular regulation of cytokine gene expression during the immune response.

Authors:  J P Viola; A Rao
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs.

Authors:  T Yamagata; K Mitani; H Oda; T Suzuki; H Honda; T Asai; K Maki; T Nakamoto; H Hirai
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes.

Authors:  Guo-Yun Chen; Hirotaka Osada; Luis F Santamaria-Babi; Reiji Kannagi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

4.  FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells.

Authors:  Kentaro Fukushima; Itaru Matsumura; Sachiko Ezoe; Masahiro Tokunaga; Masato Yasumi; Yusuke Satoh; Hirohiko Shibayama; Hirokazu Tanaka; Atsushi Iwama; Yuzuru Kanakura
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

5.  Ectopic T cell receptor-α locus control region activity in B cells is suppressed by direct linkage to two flanking genes at once.

Authors:  Stefan Knirr; Janette Gomos-Klein; Blanca E Andino; Faith Harrow; Karl F Erhard; Damian Kovalovsky; Derek B Sant'Angelo; Benjamin D Ortiz
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

Review 6.  CD154 transcriptional regulation in primary human CD4 T cells.

Authors:  Randy Q Cron
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter.

Authors:  M Brunner; M Zhang; A Genin; I-C Ho; R Q Cron
Journal:  Genes Immun       Date:  2008-08-21       Impact factor: 2.676

8.  TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.

Authors:  Y Ono; N Fukuhara; O Yoshie
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 9.  GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.

Authors:  I-Cheng Ho; Tzong-Shyuan Tai; Sung-Yun Pai
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

10.  Genomic analysis of the function of the transcription factor gata3 during development of the mammalian inner ear.

Authors:  Marta Milo; Daniela Cacciabue-Rivolta; Adam Kneebone; Hikke Van Doorninck; Claire Johnson; Grace Lawoko-Kerali; Mahesan Niranjan; Marcelo Rivolta; Matthew Holley
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.